Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer
| Author | Mozaffar Aznab | en |
| Author | Mansour Khazaei | en |
| Orcid | Mozaffar Aznab [0000-0002-1498-5205] | en |
| Issued Date | 2016-06-30 | en |
| Abstract | Stevens-Johnson syndrome has been an acute, usually self-limiting disease of the skin and mucous membranes. This case report has presented an evidence of the development Stevens - Johnson syndrome associated with combination chemotherapy administration of 5FU, gemcitabin and cisplatin in a patient with biliary tract cancer. Our case was a 54-year-old woman patient, a case of biliary tract cancer who has developed more severe symptoms of Stevens-Johnson syndrome. Diagnosis has confirmed by skin biopsy of an affected area .The patient has improved with supportive care, and during 25 day occurred recovery. Although Stevens-Johnson syndrome has been a rare toxicity, physicians should pay a special attention to the monitoring of biliary tract cancer patients on combination chemotherapy with 5FU, cisplatin and gemcitabin. | en |
| DOI | https://doi.org/10.17795/ijcp-4211 | en |
| Keyword | Stevens-Johnson Syndrome | en |
| Keyword | Malignancy | en |
| Keyword | Chemotherapy | en |
| Publisher | Brieflands | en |
| Title | Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer | en |
| Type | Case Report | en |